Seattle Children's

Running trials

• Recruiting

  Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT07864168· Source

• Recruiting

  Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

  NCT07346157· Phase 1/2· Source

• Recruiting

  Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

  NCT07226453· Phase 2· Source

• Active, not recruiting

  GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

  NCT07228117· Source

• Recruiting

  Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

  NCT07292558· Source

• Active, not recruiting

  Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

  NCT07287189· Phase 2· Source

• Active, not recruiting

  Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

  NCT06299891· Phase 2· Source

• Recruiting

  Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

  NCT07674758· Source

• Recruiting

  InvesT1D: Promoting Adolescent Investment in Diabetes Care

  NCT06384911· Source

• Active, not recruiting

  The PRISM-Social Needs (PRISM-SN) Intervention for Adolescents and Young Adults With Cancer

  NCT06242964· Source

• Active, not recruiting

  VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

  NCT04796012· Phase 1/2· Source

• Active, not recruiting

  A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

  NCT05126758· Phase 3· Source

• Enrolling by invitation

  Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

  NCT05161078· Source

• Active, not recruiting

  Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

  NCT04281485· Phase 3· Source

• Active, not recruiting

  Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

  NCT04142437· Source

• Recruiting

  Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

  NCT04174157· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes3 recruiting
• Childhood cancers2 recruiting
• Chronic kidney disease1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Spinal muscular atrophy1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Accuracy Performance Verification of the INVOS™ System in Pediatrics

  NCT05962905· Source

• Completed

  Afrezza® INHALE-1 Study in Pediatrics

  NCT04974528· Phase 3· Source

• Completed

  A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

  NCT00777036· Phase 2· Source